Company intelligence / Profile preview

Lynk Biotechnologies Pte Ltd

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

Lynk Biotech has developed a unique transdermal cream base which serves as a platform for various healthcare and cosmetic products. The company handles the entire product development lifecycle in-house, from R&D to manufacturing and distribution.

Therapeutic areas: Dermatology
Modalities: Transdermal cream base
Industry: Non-Drug Biotech

Drug pipeline

4 assets

TGC

Commercial

Indications: Joint health

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Lynk Biotechnologies Pte Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lynk Biotechnologies Pte Ltd.

Explore the full profile